Deroy & Devereaux Private Investment Counsel’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-5,300
| Closed | -$203K | – | 149 |
|
|
2019
Q1 | $203K | Sell |
5,300
-1,550
| -23% | -$59.4K | 0.02% | 150 |
|
|
2018
Q4 | $242K | Sell |
6,850
-367,069
| -98% | -$13M | 0.03% | 142 |
|
|
2018
Q3 | $14.4M | Sell |
373,919
-266,347
| -42% | -$10.3M | 1.44% | 38 |
|
|
2018
Q2 | $20.9M | Buy |
640,266
+400
| +0.1% | +$13.1K | 2.14% | 8 |
|
|
2018
Q1 | $17.5M | Sell |
639,866
-132
| -0% | -$3.61K | 1.86% | 15 |
|
|
2017
Q4 | $15.9M | Buy |
639,998
+8,571
| +1% | +$212K | 1.67% | 25 |
|
|
2017
Q3 | $18.4M | Sell |
631,427
-4,950
| -0.8% | -$144K | 2.07% | 10 |
|
|
2017
Q2 | $17.6M | Sell |
636,377
-1,255
| -0.2% | -$34.8K | 2.02% | 12 |
|
|
2017
Q1 | $15.9M | Sell |
637,632
-20,580
| -3% | -$512K | 1.84% | 16 |
|
|
2016
Q4 | $14.2M | Buy |
658,212
+122,633
| +23% | +$2.65M | 1.69% | 24 |
|
|
2016
Q3 | $12.7M | Buy |
535,579
+2,854
| +0.5% | +$67.9K | 1.61% | 35 |
|
|
2016
Q2 | $12.5M | Sell |
532,725
-165,860
| -24% | -$3.88M | 1.66% | 27 |
|
|
2016
Q1 | $13.1M | Sell |
698,585
-10,338
| -1% | -$194K | 1.79% | 19 |
|
|
2015
Q4 | $13.1M | Sell |
708,923
-10,901
| -2% | -$201K | 1.8% | 20 |
|
|
2015
Q3 | $11.8M | Buy |
719,824
+5,289
| +0.7% | +$86.8K | 1.69% | 26 |
|
|
2015
Q2 | $12.6M | Sell |
714,535
-23,625
| -3% | -$418K | 1.63% | 29 |
|
|
2015
Q1 | $13.1M | Buy |
738,160
+27,802
| +4% | +$493K | 1.62% | 28 |
|
|
2014
Q4 | $9.41M | Buy |
710,358
+6,732
| +1% | +$89.2K | 1.21% | 44 |
|
|
2014
Q3 | $8.31M | Buy |
+703,626
| New | +$8.31M | 1.25% | 45 |
|